Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs QuickMD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and QuickMD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 364 · Grade C

QuickMD

Visit QuickMD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 60 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make QuickMD a bad call — it's best for people seeking a pay-per-visit clinician consultation who understand that the pharmacy charge and prescription decision are separate. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
74
Transparency
90
32
Access Breadth
93
52
Clinical Oversight
92
79
Track Record
88
73
CoreAge RxBrief Score 94 · 60QuickMD

Price, coverage & the tracker

CoreAge RxQuickMD
Brief Score94/100 (A)60/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$99 consultation + medication extra

No membership required. Branded and compounded choices advertised; complete selected medication price and supply unconfirmed.

Completed visit nonrefundable even if requested drug declined. Cancel at least one hour ahead to avoid a $35 visit-credit deduction; pharmacy refunds are separate.

Full price details

Branded and compounded semaglutide choices advertised; complete medication quote unknown; weight-care consultation $99 per visit, medication paid separately at the chosen pharmacy

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$99 consultation + medication extra

No membership required. Branded and compounded choices advertised; complete selected medication price and supply unconfirmed.

Completed visit nonrefundable even if requested drug declined. Cancel at least one hour ahead to avoid a $35 visit-credit deduction; pharmacy refunds are separate.

Full price details

Branded and compounded tirzepatide choices advertised; complete medication quote unknown; weight-care consultation $99 per visit, medication paid separately at the chosen pharmacy

CoverageUS only; restrictions by state, confirmed at intakeWeight-care page explicitly says “Not available in LA”; other eligibility depends on clinician licensing and the patient’s location. Confirm weight-care access before paying.
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

QuickMD: Weight-care visit $99, medication extra. Completed visits are nonrefundable; cancel at least one hour ahead to avoid a $35 credit deduction. Exact pharmacy quote depends on product and coverage.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.